These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases]. Kruis W; Pohl C Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288 [No Abstract] [Full Text] [Related]
11. Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice. Tursi A; Elisei W; Brandimarte G; Giorgetti G; Penna A; Castrignano V Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):47-55. PubMed ID: 20184089 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924 [TBL] [Abstract][Full Text] [Related]
13. Management of inflammatory bowel disease in adults. Katz JA J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817 [TBL] [Abstract][Full Text] [Related]
14. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif]. Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976 [TBL] [Abstract][Full Text] [Related]
15. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045 [TBL] [Abstract][Full Text] [Related]
16. Advances in inflammatory bowel diseases in children. Michail S; Ramsy M; Soliman E Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in inflammatory bowel disease: traditional, biological or both? Van Assche G; Vermeire S; Rutgeerts P Curr Opin Gastroenterol; 2009 Jul; 25(4):323-8. PubMed ID: 19417645 [TBL] [Abstract][Full Text] [Related]
19. First-line therapies in inflammatory bowel disease. Girardin M; Manz M; Manser C; Biedermann L; Wanner R; Frei P; Safroneeva E; Mottet C; Rogler G; Schoepfer AM Digestion; 2012; 86 Suppl 1():6-10. PubMed ID: 23051720 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. Markowitz J; Grancher K; Mandel F; Daum F Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]